BRIACELL THERAP (BCTX) Competitors $0.80 -0.01 (-1.19%) Closing price 04:00 PM EasternExtended Trading$0.80 +0.00 (+0.45%) As of 07:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BCTX vs. KRON, CELU, VTVT, ARTV, ALGS, AVTX, JSPR, IPSC, ZIVO, and DTILShould you be buying BRIACELL THERAP stock or one of its competitors? The main competitors of BRIACELL THERAP include Kronos Bio (KRON), Celularity (CELU), vTv Therapeutics (VTVT), Artiva Biotherapeutics (ARTV), Aligos Therapeutics (ALGS), Avalo Therapeutics (AVTX), Jasper Therapeutics (JSPR), Century Therapeutics (IPSC), ZIVO Bioscience (ZIVO), and Precision BioSciences (DTIL). These companies are all part of the "pharmaceutical products" industry. BRIACELL THERAP vs. Its Competitors Kronos Bio Celularity vTv Therapeutics Artiva Biotherapeutics Aligos Therapeutics Avalo Therapeutics Jasper Therapeutics Century Therapeutics ZIVO Bioscience Precision BioSciences Kronos Bio (NASDAQ:KRON) and BRIACELL THERAP (NASDAQ:BCTX) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, media sentiment, risk, earnings, valuation, institutional ownership and dividends. Do institutionals & insiders believe in KRON or BCTX? 64.1% of Kronos Bio shares are held by institutional investors. Comparatively, 15.4% of BRIACELL THERAP shares are held by institutional investors. 24.4% of Kronos Bio shares are held by insiders. Comparatively, 5.7% of BRIACELL THERAP shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has stronger valuation & earnings, KRON or BCTX? BRIACELL THERAP has lower revenue, but higher earnings than Kronos Bio. Kronos Bio is trading at a lower price-to-earnings ratio than BRIACELL THERAP, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKronos Bio$9.85M5.45-$86.08M-$1.07-0.82BRIACELL THERAPN/AN/A-$4.79M-$8.32-0.10 Does the media prefer KRON or BCTX? In the previous week, BRIACELL THERAP had 2 more articles in the media than Kronos Bio. MarketBeat recorded 2 mentions for BRIACELL THERAP and 0 mentions for Kronos Bio. BRIACELL THERAP's average media sentiment score of 1.89 beat Kronos Bio's score of 0.00 indicating that BRIACELL THERAP is being referred to more favorably in the news media. Company Overall Sentiment Kronos Bio Neutral BRIACELL THERAP Very Positive Is KRON or BCTX more profitable? BRIACELL THERAP has a net margin of 0.00% compared to Kronos Bio's net margin of -701.53%. Kronos Bio's return on equity of -64.22% beat BRIACELL THERAP's return on equity.Company Net Margins Return on Equity Return on Assets Kronos Bio-701.53% -64.22% -47.17% BRIACELL THERAP N/A -479.97%-182.26% Do analysts rate KRON or BCTX? Kronos Bio currently has a consensus price target of $1.63, indicating a potential upside of 84.66%. BRIACELL THERAP has a consensus price target of $32.00, indicating a potential upside of 3,903.00%. Given BRIACELL THERAP's stronger consensus rating and higher possible upside, analysts plainly believe BRIACELL THERAP is more favorable than Kronos Bio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Kronos Bio 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33BRIACELL THERAP 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk & volatility, KRON or BCTX? Kronos Bio has a beta of 1.64, suggesting that its stock price is 64% more volatile than the S&P 500. Comparatively, BRIACELL THERAP has a beta of 1.27, suggesting that its stock price is 27% more volatile than the S&P 500. SummaryKronos Bio and BRIACELL THERAP tied by winning 7 of the 14 factors compared between the two stocks. Get BRIACELL THERAP News Delivered to You Automatically Sign up to receive the latest news and ratings for BCTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BCTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BCTX vs. The Competition Export to ExcelMetricBRIACELL THERAPMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.48M$3.07B$5.70B$9.51BDividend YieldN/A2.36%4.69%4.01%P/E Ratio-0.1021.0428.0720.05Price / SalesN/A284.46448.5799.42Price / CashN/A42.7636.2258.56Price / Book-0.368.378.665.87Net Income-$4.79M-$55.19M$3.25B$258.55M7 Day Performance0.14%5.89%4.20%2.23%1 Month Performance-72.72%17.63%10.82%12.76%1 Year Performance-93.08%5.09%34.70%19.36% BRIACELL THERAP Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BCTXBRIACELL THERAP2.2902 of 5 stars$0.80-1.2%$32.00+3,903.0%-92.9%$5.48MN/A-0.108Positive NewsKRONKronos BioN/A$0.88+1.5%$1.63+84.7%-33.3%$53.72M$9.85M-0.82100CELUCelularity0.1408 of 5 stars$2.24+6.2%N/A+3.6%$53.65M$54.22M-0.85220News CoverageUpcoming EarningsVTVTvTv Therapeutics1.6257 of 5 stars$16.71-1.8%$35.50+112.4%-31.6%$53.31M$1.02M-5.559News CoveragePositive NewsARTVArtiva Biotherapeutics2.6374 of 5 stars$2.18+6.9%$17.80+716.5%-70.8%$53.11M$250K0.0081ALGSAligos Therapeutics4.3084 of 5 stars$8.69+3.9%$70.00+705.5%-33.9%$53.10M$3.94M-0.5090News CoveragePositive NewsAVTXAvalo Therapeutics3.5428 of 5 stars$4.90+2.5%$30.00+512.2%-43.4%$53.06M$441K0.0040News CoveragePositive NewsJSPRJasper Therapeutics3.7197 of 5 stars$3.47-1.1%$29.75+757.3%-84.9%$52.13MN/A-0.6620IPSCCentury Therapeutics3.5296 of 5 stars$0.60-0.1%$4.20+600.1%-72.3%$51.69M$114.90M-2.07170Positive NewsZIVOZIVO BioscienceN/A$13.50flatN/A+32.6%$51.53M$15.85K-2.7710DTILPrecision BioSciences4.0794 of 5 stars$4.64+4.3%$47.00+912.9%-49.7%$51.46M$68.70M-2.31200Upcoming Earnings Related Companies and Tools Related Companies KRON Alternatives CELU Alternatives VTVT Alternatives ARTV Alternatives ALGS Alternatives AVTX Alternatives JSPR Alternatives IPSC Alternatives ZIVO Alternatives DTIL Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BCTX) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BRIACELL THERAP Please log in to your account or sign up in order to add this asset to your watchlist. Share BRIACELL THERAP With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BCTX Stock Alerts